Post-transplant acute limbic encephalitis: Difference between revisions
From IDWiki
(→) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
== Background == |
== Background == |
||
* Caused by [[HHV-6B]] |
* Caused by [[HHV-6B]][[CiteRef::ongrádi2016ro]] |
||
== Clinical |
== Clinical Manifestations == |
||
* Onset 2 weeks to 2 months after transplant |
* Onset 2 weeks to 2 months after transplant |
||
* Presents with confusion, amnesia, hallucinations |
* Presents with confusion, amnesia, hallucinations |
||
| Line 14: | Line 14: | ||
* Treat any possible concomitant risk factors such as hyponytremia |
* Treat any possible concomitant risk factors such as hyponytremia |
||
* Antivirals: [[Is treated by::acyclovir]], [[Is treated by::ganciclovir]], or [[Is treated by::foscarnet]] for 10 days to 4 weeks |
* Antivirals: [[Is treated by::acyclovir]], [[Is treated by::ganciclovir]], or [[Is treated by::foscarnet]] for 10 days to 4 weeks |
||
== Further Reading == |
|||
* Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. ''Neurology''. 2007;69(2):156-165. DOI: [https://doi.org/10.1212/01.wnl.0000265591.10200.d7 10.1212/01.wnl.0000265591.10200.d7] |
|||
[[Category:Immunocompromised hosts]] |
[[Category:Immunocompromised hosts]] |
||
Latest revision as of 17:07, 19 July 2020
- Limbic encephalitis syndrome following hematopoietic stem cell transplantation
Background
Clinical Manifestations
- Onset 2 weeks to 2 months after transplant
- Presents with confusion, amnesia, hallucinations
- Can cause seizures
- Hyponatremia is common
Management
- Treat seizures with antiepileptic medications
- Treat any possible concomitant risk factors such as hyponytremia
- Antivirals: acyclovir, ganciclovir, or foscarnet for 10 days to 4 weeks
Further Reading
- Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156-165. DOI: 10.1212/01.wnl.0000265591.10200.d7
References
- ^ Joseph Ongrádi, Dharam V. Ablashi, Tetsushi Yoshikawa, Balázs Stercz, Masao Ogata. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. Journal of NeuroVirology. 2016;23(1):1-19. doi:10.1007/s13365-016-0473-0.
